MedPath

Comparative effectiveness of low-dose versus standard-dose tissue plasminogen activator for acute ischemic stroke patients

Not Applicable
Recruiting
Conditions
Diseases of the nervous system
Registration Number
KCT0001048
Lead Sponsor
Seoul National University Bundang Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
1600
Inclusion Criteria

1) Admitted between November 2009 and March 2013 / 2) Neuroimage-documented ischemic stroke / 3) within 4.5 hours from last seen normal time / 4) tPA-treated cases

Exclusion Criteria

1) No information on tPA dose / 2) No information on mRS score at 3 month / 3) No information on symptomatic hemorrhagic transformation

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
mRS score at 3 months after stroke onset;symptomatic hemorrhagic transformation
Secondary Outcome Measures
NameTimeMethod
mRS score at discharge
© Copyright 2025. All Rights Reserved by MedPath